Cardiac Dimensions snags $53m for mitral valve device
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s …
Post
-
-
Brainomix concludes $18m fund raise to strengthen US presence
UK-based Brainomix has completed a £14m ($18m) Series C funding round to advance commercial expansion in the US. A spinout of …
-
Medtronic’s Evolut trial outcome could shift US TAVR market
Medtronic has released the two-year results from the clinical trial comparing its Evolut system to Edwards Lifesciences’ SAPIEN system. The …
-
USPTO issues patent for Exactech’s soft tissue balancing technology
The US Patent and Trademark Office (USPTO) has issued patent 12,239,384 for Exactech’s Newton soft tissue balancing technology. This patent is …
-
Proscia scoops $50m for AI-driven pathology advancement
A US-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven digital pathology platform. Currently …
-
Leadoptik and Stanford Medicine to explore imaging in lung biopsy procedures
Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage in lung cancer biopsy. This …
-
Significant growth expected in the Middle East and Africa’s cardiac valve repair devices market
Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of cardiac valve repair devices …
-
Medit and Pearl unite to improve dental diagnostics with AI
Medit and Pearl have announced a collaboration to integrate the latter’s AI-powered offerings into the Medit Link platform, aimed at …
-
Abbott launches portable concussion blood test in UK
Abbott has launched its portable whole blood test for assessing suspected mild traumatic brain injuries (mTBI/concussions) in the UK. Tests for …
-
UVA School of Medicine creates tool to predict drug impact on biological process
School of Medicine scientists at the University of Virginia (UVA), US have developed an AI tool, LogiRx, designed to expedite …
-
FDA tags Medtronic embolisation device recall as Class I
The US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as Class I …
-
NVIDIA and GE HealthCare team up for autonomous diagnostic imaging
NVIDIA and GE HealthCare have entered a new collaboration to develop autonomous diagnostic imaging tools, initially focusing on X-ray and …
-
AccuStem Sciences acquires licence for lung cancer screening test
Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, which aims to …
-
Laplace gains funding for transcatheter tricuspid valve replacement trial
Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the successful completion of a Series …
-
AngioInsight to assess AI-powered platform for cardiovascular diagnosis
US-based AngioInsight is set to launch its pivotal SMARTFLOW clinical study to assess its AI-powered, software-only AngioAI+ platform’s diagnostic accuracy …
